GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hayat Pharmaceutical Industries Co (AMM:HPIC) » Definitions » Net-Net Working Capital

Hayat Pharmaceutical Industries Co (AMM:HPIC) Net-Net Working Capital : JOD1.27 (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Hayat Pharmaceutical Industries Co Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Hayat Pharmaceutical Industries Co's Net-Net Working Capital for the quarter that ended in Mar. 2025 was JOD1.27.

The industry rank for Hayat Pharmaceutical Industries Co's Net-Net Working Capital or its related term are showing as below:

AMM:HPIC's Price-to-Net-Net-Working-Capital is ranked better than
88.59% of 403 companies
in the Drug Manufacturers industry
Industry Median: 7.93 vs AMM:HPIC: 2.23

Hayat Pharmaceutical Industries Co Net-Net Working Capital Historical Data

The historical data trend for Hayat Pharmaceutical Industries Co's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hayat Pharmaceutical Industries Co Net-Net Working Capital Chart

Hayat Pharmaceutical Industries Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.53 0.99 0.74 0.68

Hayat Pharmaceutical Industries Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.89 0.34 0.68 1.27

Competitive Comparison of Hayat Pharmaceutical Industries Co's Net-Net Working Capital

For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hayat Pharmaceutical Industries Co's Price-to-Net-Net-Working-Capital Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Hayat Pharmaceutical Industries Co's Price-to-Net-Net-Working-Capital falls into.


;
;

Hayat Pharmaceutical Industries Co Net-Net Working Capital Calculation

Hayat Pharmaceutical Industries Co's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net-Net Working Capital(A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(9.045+0.75 * 3.119+0.5 * 3.549-6.652
-0-0)/9.500
=0.68

Hayat Pharmaceutical Industries Co's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(8.152+0.75 * 12.203+0.5 * 4.087-7.242
-0-0)/9.500
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Hayat Pharmaceutical Industries Co  (AMM:HPIC) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Hayat Pharmaceutical Industries Co Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Hayat Pharmaceutical Industries Co's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Hayat Pharmaceutical Industries Co Business Description

Traded in Other Exchanges
N/A
Address
Nile St. Al-Rajeeb, P.O. Box 1564, Amman, JOR, 11118
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. Its principal activity is producing human and veterinary in all its forms and medical stickers and stockings. The company is also involved in the production of medical supplies, body care lotions, cosmetics, and initiating marketing campaigns as well as import and export operations. It has developed and registered a hundred sixteen different dosage forms/pack sizes in the Jordan market representing fifty six different brands (molecules) in various therapeutic areas. Its products include Cardiovascular system, Infectious disease Dermatology, Gastrointestinal system, and Respiratory system.

Hayat Pharmaceutical Industries Co Headlines

No Headlines